A survey of extraction techniques for drugs of abuse in urine

被引:9
|
作者
Wilson, JF [1 ]
Smith, BL [1 ]
Toseland, PA [1 ]
Watson, ID [1 ]
Williams, J [1 ]
Thomson, AH [1 ]
Capps, NE [1 ]
Sweeney, G [1 ]
Sandle, LN [1 ]
机构
[1] Univ Wales Coll Med, Dept Pharmacol Therapeut & Toxicol, Cardiff CF14 4XN, S Glam, Wales
关键词
amfetamine; morphine; cocaine; liquid-liquid extraction; solid phase extraction;
D O I
10.1016/S0379-0738(00)00383-2
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
Sixty nine participants in the United Kingdom national external quality assessment scheme for drugs of abuse in urine reported details of their sample extraction technique by questionnaire. Laboratories were categorised by differences in technique and their analytical test results compared for samples containing D-amfetamine 0.4 (4) and 0.8 (3) mg/l, morphine 0.4 (4) and 0.8 (4) mg/l, and benzoylecgonine 0.15/0.2 (2) and 0.45/0.5 (4) mg/l. Values in parentheses are numbers of samples, For amfetamine, there was no significant difference in the frequency of true positive results between liquid-liquid or solid phase extraction and the Toxi-Lab A system at 0.8 mg/l. Toxi-Lab A gave significantly fewer positives when operating below its specified threshold at 0.4 mg/l. Paradoxically, laboratories using >5 mi urine volume performed less well. Acidification of the extract before volume reduction gave significantly more true positives. For extraction of morphine, solid phase systems significantly outperformed both liquid-liquid acid the Toxi-Lab A system at both 0.8 and 0.4 mg/l. No significant differences between extraction techniques were demonstrated for analysis of benzoylecgonine. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:23 / 27
页数:5
相关论文
共 50 条
  • [41] Potentiality of miniaturized techniques for the analysis of drugs of abuse
    Fanali, Chiara
    D'Orazio, Giovanni
    Gentili, Alessandra
    Fanali, Salvatore
    ELECTROPHORESIS, 2022, 43 (1-2) : 190 - 200
  • [42] Evaluation of detection techniques and laboratory proficiency in testing for drugs of abuse in urine: an external quality assessment scheme using clinically realistic urine samples
    Wilson, JF
    Smith, BL
    ANNALS OF CLINICAL BIOCHEMISTRY, 1999, 36 : 592 - 600
  • [43] PERFORMANCE EFFECTS OF DRUGS OF ABUSE - A METHODOLOGICAL SURVEY
    FOLTIN, RW
    EVANS, SM
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1993, 8 (01) : 9 - 19
  • [44] Electromembrane extraction of drugs of abuse and prescription drugs from micropulverized hair
    Schueller, Maria
    Bergh, Marianne Skov-Skov
    Pedersen-Bjergaard, Stig
    Oiestad, Elisabeth Leere
    JOURNAL OF ANALYTICAL TOXICOLOGY, 2024, 48 (07) : 489 - 498
  • [45] Detection times of drugs of abuse in blood, urine, and oral fluid
    Verstraete, AG
    THERAPEUTIC DRUG MONITORING, 2004, 26 (02) : 200 - 205
  • [46] Drugs of abuse screening in urine: A five-year experience
    Dvornik, S
    Bilic-Zulle, L
    Fisic, E
    PERIODICUM BIOLOGORUM, 2001, 103 (04) : 357 - 360
  • [47] THE EFFECTS OF ADULTERATING AGENTS ON FPIA ANALYSIS OF URINE FOR DRUGS OF ABUSE
    SCHWARZHOFF, R
    CODY, JT
    JOURNAL OF ANALYTICAL TOXICOLOGY, 1993, 17 (01) : 14 - 17
  • [48] Negative results for urine drugs of abuse in diabetic ketoacidosis.
    Broussard, LA
    Blakeney, J
    Pittman, T
    Presley, L
    CLINICAL CHEMISTRY, 1997, 43 : 467 - 467
  • [49] Screening for drugs of abuse: which matrix, oral fluid or urine?
    Allen, Keith R.
    ANNALS OF CLINICAL BIOCHEMISTRY, 2011, 48 : 531 - 541
  • [50] High Throughput Sample Preparation Method for Drugs of Abuse in Urine
    House, David
    Zang, Xuejun
    Milasinovic, Slobodan
    Oroskar, Asha
    Oroskar, Anil
    LC GC NORTH AMERICA, 2018, 36 (02) : 20 - 22